Skip to main content
Report File
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Components
Centers for Medicare and Medicaid Services
Report Number
OEI-05-20-00480
Report Type
Inspection / Evaluation
Number of Recommendations
2
Questioned Costs
$0
Funds for Better Use
$0

Open Recommendations

This report has 2 open recommendations.
Recommendation Number Significant Recommendation Recommended Questioned Costs Recommended Funds for Better Use Additional Details
22-E-05-014.01 No $0 $0

CMS should Encourage Part D plans to increase access to and use of biosimilars.

22-E-05-014.02 No $0 $0

CMS should Monitor Part D plans’ submitted formularies to determine whether they discourage beneficiaries from using biosimilars

Department of Health & Human Services OIG

United States